Plasma-activated media for use thereof in the treatment of respiratory diseases

Abstract

The proposed invention relates to plasma-activated liquid media for use thereof in the treatment of diseases, whether viral and/or bacterial (including antibiotic-resistant bacteria), of the upper and lower respiratory tracts in humans and animals. These media exhibit an antiviral and antibacterial activity based on the oxidative stress that they cause in the microorganisms and cells affected by the same. Said oxidative stress is caused by reactive oxygen and nitrogen molecule species dissolved in the plasma-activated medium and is tolerated by the healthy cells, but it inactivates said harmful microorganisms. The proposed use is useful for fighting viral and/or bacterial respiratory infections.

Dependencies are inferred from the claim text.